Engineered cells as medicines
Sana Biotechnology is focused on creating engineered cells as medicines to repair and control genes or replace damaged cells, targeting diseases like diabetes, B-cell cancers, and autoimmune disorders. With operations in Seattle, Cambridge, and South San Francisco, Sana leverages expertise in cell and gene therapy to develop curative therapies.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountFeb 2021
Jun 2020
Jan 2019
Jun 2018
Jan 2018
Jan 2018
Create a free account to see which investors have funded this company.
Create Free Account
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
